Bonus Biogroup (BONS)

Currency in ILS
24.1
-1.0(-3.98%)
Closed·
BONS Scorecard
Full Analysis
Stock has taken a big hit over the last week
BONS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
24.025.5
52 wk Range
9.027.4
Key Statistics
Bid/Ask
24.10 / 24.70
Prev. Close
25.1
Open
25.1
Day's Range
24-25.5
52 wk Range
9-27.4
Volume
1.51M
Average Volume (3m)
2.07M
1-Year Change
70.92%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BONS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Bonus Biogroup News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Bonus Biogroup Company Profile

Bonus BioGroup Ltd., a clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy. The company’s products under development include BonoFill for the treatment of bone tissue regeneration in maxillofacial and orthopedic indications, and defects in limb and jaw bones which is in Phase II clinical trial, as well as in a preclinical stage for the treatment of bone augmentation in osteoporosis patients. It also develops MesenCure for the treatment of COVID patients suffering from pneumonia and ARDS which is in phase III clinical trial, as well as in preclinical stage for the treatment of other inflammations and tissue damage, including chronic kidney diseases, osteoarthritis, and cytokine release syndrome. The company was formerly known as Oceana Advanced Industries Ltd. Bonus BioGroup Ltd. was incorporated in 1981 and is headquartered in Haifa, Israel.

Compare BONS to Peers and Sector

Metrics to compare
BONS
Peers
Sector
Relationship
P/E Ratio
−10.1x−3.6x−0.5x
PEG Ratio
−4.19−0.040.00
Price/Book
40.5x1.7x2.6x
Price / LTM Sales
-14.7x3.3x
Upside (Analyst Target)
-449.5%43.3%
Fair Value Upside
Unlock−6.1%6.9%Unlock

Earnings

Latest Release
Mar 31, 2025
EPS / Forecast
-0.01 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

BONS Income Statement

People Also Watch

5,600
TEVA
+0.72%
68,500
DLEKG
-1.82%
50.91
DIOD
+7.93%
20,670
KLIL
+2.58%
4,040
CRSM
+1.94%

FAQ

What Stock Exchange Does Bonus Biogroup Trade On?

Bonus Biogroup is listed and trades on the Tel Aviv Stock Exchange stock exchange.

What Is the Stock Symbol for Bonus Biogroup?

The stock symbol for Bonus Biogroup is "BONS."

What Is the Bonus Biogroup Market Cap?

As of today, Bonus Biogroup market cap is 281.47M.

What Is Bonus Biogroup's Earnings Per Share (TTM)?

The Bonus Biogroup EPS (TTM) is -0.02.

From a Technical Analysis Perspective, Is BONS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Bonus Biogroup Stock Split?

Bonus Biogroup has split 1 times.

How Many Employees Does Bonus Biogroup Have?

Bonus Biogroup has 49 employees.

What is the current trading status of Bonus Biogroup (BONS)?

As of 11 Aug 2025, Bonus Biogroup (BONS) is trading at a price of 24.10, with a previous close of 25.10. The stock has fluctuated within a day range of 24.00 to 25.50, while its 52-week range spans from 9.00 to 27.40.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.